USA

Some US employers to drop GLP-1 coverage by 2027

(NewsNation) — Some U.S. employers say they plan to drop insurance GLP-1 Drugs for weight loss next year, according to a recent report.

From the report Health Business Group It surveyed businesses and found that about 10% of employers who currently insure drugs said they would not continue that coverage until 2027.

“Our findings demonstrate employers’ major concerns about these drugs in terms of cost and financial sustainability,” said Ellen Kelsay, president and CEO of Business Group on Health. “In the face of expected double-digit healthcare cost increases, driven largely by GLP-1s and overall prescription drug costs, companies cannot ignore the fact that GLP-1s have significant impacts on healthcare budgets and overall affordability.”

Using marijuana for sleep is not harmless; can trap people in a cycle of addiction

One company has already decided to remove coverage for weight loss drugs. Health insurance company Cigna, according to Reuters end scope He said the treatments would begin in July and told his employees they could purchase them elsewhere.

The weight-loss drugs are available at discounted prices through some drug manufacturers’ websites, as well as through a deal with the Trump administration. TrumpRx area.

Industry experts said demand for the drugs has increased this year, driven by oral options that attract people who have never tried GLP-1s and keep employer costs high.

The Business Group on Health survey also found that about 72 percent of companies will continue to cover weight-loss treatments in 2027.

Go to NewsNation for the latest news, weather, sports and streaming video.